Silencing galectin 1 protein shrinks liver cancer tumors in mice

Researchers at UC Davis Comprehensive Cancer Center have shown that inhibiting a specific protein using gene therapy can shrink hepatocellular carcinoma (HCC) in mice.

Viking’s $350M offering; Baker Brothers leads another PIPE

Plus, news about Applied Therapeutics, Beam Therapeutics, Janux Therapeutics and more: Viking Therapeutics sells off $350M of stock following positive obesity drug data: On the

February 29, 2024

Pharmalittle: Alzheimer’s diagnosis revamp embraces rating scale similar to cancer; FTC seeks info on Pfizer-Seagen deal

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of phone

July 17, 2023

Nyxoah Reports Third Quarter Financial and Operating Results – Biotech Investments

EQS-News: Nyxoah SA. / Key word(s): Quarter Results Nyxoah Reports Third Quarter Financial and Operating Results 06.11.2024 / 22:05 CET/CEST The issuer is solely responsible

November 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.